Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | AKR1B10 | O60218 | 4/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6523139 | 0.81 | MEN1 (0.50) | HCAR2ATMMAPTHPGD | |
| SCHEMBL3695735 | 0.80 | ATM (0.62) | HCAR2ATMAKR1B10AKR1B1MAPT | |
| SCHEMBL7044306 | 0.79 | HCAR2 (0.55) | HCAR2AKR1B10AKR1B1MAPTTDP1 | |
| SCHEMBL6520700 | 0.78 | TDP1 (0.44) | PLA2G4BTDP1HPGDHDAC3 | |
| SCHEMBL6520752 | 0.78 | HCAR2 (0.68) | HCAR2AKR1B10AKR1B1MAPTTDP1 | |
| SCHEMBL13387859 | 0.77 | AKR1B10 (0.62) | AKR1B10AKR1B1MAOB | |
| SCHEMBL28104396 | 0.77 | AKR1B10 (0.62) | AKR1B10AKR1B1MAOB | |
| SCHEMBL2890708 | 0.77 | ATM (0.76) | HCAR2ATMMAPTHPGD | |
| SCHEMBL18264191 | 0.77 | ATM (0.76) | HCAR2ATMMAPTHPGD | |
| SCHEMBL9869162 | 0.77 | ATM (0.76) | HCAR2ATMMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | HCAR2 3143/4885ATM 4559/4885AKR1B10 2430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.